Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

INTRODUCTION: The safety profile of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) is well established. TCZ was approved to treat giant cell arteritis (GCA) in 2017 in the USA and Europe, and its safety profile in patients with GCA continues to be defined. The objective of this analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gale, Sara, Trinh, Huong, Tuckwell, Katie, Collinson, Neil, Stone, John H., Sarsour, Khaled, Pei, Jinglan, Best, Jennie, Birchwood, Christine, Mohan, Shalini V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393272/
https://www.ncbi.nlm.nih.gov/pubmed/30707391
http://dx.doi.org/10.1007/s40744-019-0139-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393272/
https://www.ncbi.nlm.nih.gov/pubmed/30707391
http://dx.doi.org/10.1007/s40744-019-0139-5

Ejemplares similares